Economic aspects of our business
Crucell’s core business is protecting people from illness and death caused by infectious diseases. We aim for financial profitability, but also to bring the greatest possible benefit to human health worldwide. These two goals are inextricably linked. Our solid balance sheet and strong cash position demonstrate the sustainability of our company and of the healthcare benefits we deliver.
Crucell is making progress with regard to reporting its CSR activities and this section of the 2008 Annual Report marks the beginning of a more comprehensive, transparent approach to CSR. Our efforts to develop a more comprehensive management system will certainly contribute to the achievement of this ambition. This year we have not chosen to perform a third party verification of our CSR chapter and data. We see this as a possible future option that could strengthen our CSR performance.
Crucell is a rapidly growing pharmaceutical company with ambitious goals and a clear strategy for sustainable growth. By optimizing our business performance we are continuously increasing the number of people we can protect from illness and death caused by infectious diseases. Crucell is fully committed to being a good corporate citizen and conducting business in an honest and ethical way with the lowest possible environmental footprint.
Crucell welcomes any feedback with regard to activities and disclosure around CSR on: csr@crucell.com.